211 related articles for article (PubMed ID: 10951709)
21. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
[TBL] [Abstract][Full Text] [Related]
23. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
24. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
25. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
[TBL] [Abstract][Full Text] [Related]
26. Role of 131I in the treatment of well differentiated thyroid cancer.
Woodrum DT; Gauger PG
J Surg Oncol; 2005 Mar; 89(3):114-21. PubMed ID: 15719384
[TBL] [Abstract][Full Text] [Related]
27. Radioactive iodine treatment in medullary thyroid carcinoma.
Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
[TBL] [Abstract][Full Text] [Related]
28. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
29. Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients.
Pötzi C; Moameni A; Karanikas G; Preitfellner J; Becherer A; Pirich C; Dudczak R
Clin Endocrinol (Oxf); 2006 Oct; 65(4):519-23. PubMed ID: 16984246
[TBL] [Abstract][Full Text] [Related]
30. Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer.
Sarkar SD; Beierwaltes WH; Gill SP; Cowley BJ
J Nucl Med; 1976 Jun; 17(6):460-4. PubMed ID: 944243
[TBL] [Abstract][Full Text] [Related]
31. [Rare adverse effect of discontinuation of levothyroxine treatment for 131I ablation of thyroid remnant in a patient with differentiated thyroid cancer].
Luque-Ramírez M; Gómez Ramírez J; Azcárate Villalón A; Martín Pérez E; Larrañaga Barrera E
Endocrinol Nutr; 2013; 60(7):412-4. PubMed ID: 23271037
[No Abstract] [Full Text] [Related]
32. Thyroid diseases in pregnancy.
Gärtner R
Curr Opin Obstet Gynecol; 2009 Dec; 21(6):501-7. PubMed ID: 19797950
[TBL] [Abstract][Full Text] [Related]
33. [Pregnancy in women with thyroid cancer treated with suppressive doses of L-thyroxine].
Jastrzebska H; Gietka-Czernel M; Zgliczyński S; Czech W; Lewartowska A; Debski R
Wiad Lek; 2001; 54 Suppl 1():389-97. PubMed ID: 12182055
[TBL] [Abstract][Full Text] [Related]
34. 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study.
Ceccarelli C; Bencivelli W; Morciano D; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2001 Aug; 86(8):3512-5. PubMed ID: 11502772
[TBL] [Abstract][Full Text] [Related]
35. [Thyroid neoplasms and pregnancy].
Balázs G; Lukács G; Csáky G; Makár V
Chirurg; 1980 Jan; 51(1):29-31. PubMed ID: 7389492
[TBL] [Abstract][Full Text] [Related]
36. The changes in the thyroid gland after irradiation with 131I or partial thyroidectomy for thyrotoxicosis.
Kennedy JS; Thomson JA
J Pathol; 1974 Feb; 112(2):65-81. PubMed ID: 4834051
[No Abstract] [Full Text] [Related]
37. The indications for ablating normal thyroid tissue with 131I in differentiated thyroid cancer.
Goolden AW
Clin Endocrinol (Oxf); 1985 Jul; 23(1):81-6. PubMed ID: 3896581
[No Abstract] [Full Text] [Related]
38. Thyroid dysfunction following radiotherapy for head and neck cancer.
Turner SL; Tiver KW; Boyages SC
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):279-83. PubMed ID: 7836081
[TBL] [Abstract][Full Text] [Related]
39. Drug therapy alternatives in the treatment of thyroid cancer.
O'Doherty MJ; Coakley AJ
Drugs; 1998 Jun; 55(6):801-12. PubMed ID: 9617595
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Follow-Up for Differentiated Thyroid Carcinoma Patients: A Reconsideration.
van der Wardt RA; Persoon AC; Klein Hesselink EN; Links TP
Thyroid; 2017 Mar; 27(3):475-476. PubMed ID: 28049373
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
